Clinical Trial Update: Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a three-drug regimen (vemurafenib, cetuximab, and irinotecan hydrochloride) in patients with metastatic or unresectable solid tumors, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: BRAF NP_004324.2:p.V600X, KRAS wt Allele | Phase 1 | Status: COMPLETED